Literature DB >> 19726780

Immunologic aspects of chronic obstructive pulmonary disease.

Joaquin Lamela, Francisco Vega.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19726780     DOI： 10.1056/NEJMc091370

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  A novel AMPK activator hernandezine inhibits LPS-induced TNFα production.

Authors:  Ping Li; Xiaofang Li; Yonghong Wu; Manxiang Li; Xiaochuang Wang
Journal:  Oncotarget       Date:  2017-06-05

2.  miR-135b-5p inhibits LPS-induced TNFα production via silencing AMPK phosphatase Ppm1e.

Authors:  Ping Li; Jian-Bo Fan; Yanxia Gao; Ming Zhang; Li Zhang; Ning Yang; Xiaojing Zhao
Journal:  Oncotarget       Date:  2016-11-22

3.  RIP3-dependent necroptosis contributes to the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Dongshi Chen; Alyssa D Gregory; Xiaoyun Li; Jianxin Wei; Christine L Burton; Gregory Gibson; Stephen J Scott; Claudette M St Croix; Yingze Zhang; Steven D Shapiro
Journal:  JCI Insight       Date:  2021-06-22

4.  AS-703026 Inhibits LPS-Induced TNFα Production through MEK/ERK Dependent and Independent Mechanisms.

Authors:  Ping Li; Yonghong Wu; Manxiang Li; Xiaojuan Qiu; Xiaoyan Bai; Xiaojing Zhao
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

5.  Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway.

Authors:  Fang Zhang; Tao Pan; Xiaohui Wu; Xingchun Gao; Zhikui Li; Xinling Ren
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.